- Home
- TNDM
as 10-17-2024 4:00pm EST
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | San Diego |
| Market Cap: | 2.7B | IPO Year: | 2013 |
| Target Price: | $53.27 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.10 | EPS Growth: | N/A |
| 52 Week Low/High: | $13.82 - $53.69 | Next Earning Date: | 11-06-2024 |
| Revenue: | $796,002,000 | Revenue Growth: | 0.72% |
| Revenue Growth (this year): | 21.53% | Revenue Growth (next year): | 11.81% |
Latest Tandem Diabetes Care Inc. News
TNDM Breaking Stock News: Dive into TNDM Ticker-Specific Updates for Smart Investing
GuruFocus.com
8 days ago
Tandem Diabetes Care Inc (TNDM) Q2 2024 Earnings Call Highlights: Strong Sales Growth and ...
Argus Research
9 days ago
TNDM: Lowering target price to $36.00
MT Newswires
14 days ago
--Goldman Sachs Initiates Tandem Diabetes Care at Neutral With $46 Price Target
Business Wire
15 days ago
Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024
Benzinga
15 days ago
Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says
Investing.com
16 days ago
This pharma stock offers an attractive risk-reward says RBC
Morningstar Research
16 days ago
Analyst Report: Tandem Diabetes Care, Inc.
Motley Fool
16 days ago
Why Tandem Diabetes Care Stock Took It on the Chin Tuesday
Compare TNDM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TNDM Tandem Diabetes Care Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.